In this webinar, discover how to get the most out of your patient engagement programs while protecting your brand from regulatory non-compliance.

This webinar roundtable explores interesting technologies, the scientific issues, the clinical opportunities for developing multivalent biologics platforms, whether certain technologies, such as antibodies, their fragments, or non-antibody scaffolds, are superior to others, the pros and cons of such bispecifics for improving management of patients, and licensing and commercial strategies.

In this whitepaper, our guest experts reveal how to avoid the seven top M&A deal killers.

并购交易中的意外事件可能会导致交易延迟，甚至完全破坏交易。但如果您知道如何预防这些意外事件，它们是可以避免的。

인수 합병 거래 중 예상하지 못한 일이 벌어진다면 거래의 지연을 야기할 수 있으며 심지어 거래를 완전히 무마시킬 수도 있습니다. 그러나 그러한 상황을 대비하여 불미스러운 일을 피할 수 있습니다.

DELIVER A SLICK, FAST ONBOARDING PROCESS

Get the strategies and insights to create a realistic term sheet that everyone can agree to.

Surprises during M&A transactions can cause delays, even derail deals completely. But they can be avoided if you know.

In this webinar, Patrick Stroth of Rubicon M&A Insurance Services dives into the role representations and warranties insurance will play in your next M&A transaction.

This all-purpose due diligence checklist contains a list of all the standard documents any buyer or partner might want to see.
.

In this whitepaper, learn what is artificial intelligence and how is it being applied to drug discovery, and much more.

This whitepaper explores the importance of establishing early goals and objectives for the process, how to get the right people to ask the right questions in advance of the process, how to build credibility by defining goals and demonstrating they can be achieved, and much more.